Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 29;10:15982. doi: 10.1038/s41598-020-72544-z

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Alluvial plots depicting the change from PI-RADS v2.0 assessments to v2.1 assessment for peripheral (left) and transition zone (right) lesions. Lesion biopsy status is encoded as follows: red: clinically significant (Gleason ≥ 3 + 4), orange non-significant (Gleason 3 + 3) and grey no cancer. Cancer frequencies in category 4 and 5 in PZ and in category 5 in TZ were high in both versions. Variation between the two scoring systems is seen especially in lower scores 1–3. In the PZ, 11 formerly category 2 lesions were upgraded to category 3 in PI-RADS v2.1. Among these only one GS ≥ 7 tumor was confirmed. In the TZ, 11 TZ lesions were downgraded from category 2 into category 1 in v2.1, all of which showed no tumor upon biopsy. 12 formerly category 2 lesions in the TZ were upgraded to category 3 in v2.1, one of them was a GS ≥ 7 cancer. V version, PZ peripheral zone, TZ transition zone, GS Gleason Score.